The company sees surging demand for its remote monitoring technology and solutions from the pandemic and much of this is likely to last post-pandemic. However, the exact monetary effect is […]

The company delivered another good quarter and has again raised the full-year outlook while the shares have now pulled back a bit. The shares remain fully valued though, but that […]

A solid, growing medical monitoring device producer which keeps adding customers and new products fueling growth. Earnings are growing faster due to operational leverage and cash flows used to buy […]

Masimo has unique products that set the company up for a continuation of years of steady growth. However, the share price has grown much faster than the underlying growth, and […]

Masimo is a company that is likely to experience good top and probably even better bottom-line growth. This is driven by innovation and a cooperation deal with a big competitor […]